RCT in 418 patients with coronary in-stent restenosis: sirolimus drug-eluting balloon was non-inferior to usual care (repeat DES or balloon angioplasty) for 1-year target lesion failure (16.2% vs 14.5%), but not non-inferior to DES in single-layer restenosis (14.2% vs 6.5%).
RCTn = 418
Cutlip et al. Sirolimus-Eluting Balloon vs Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis